Yes, Sylfirm X is FDA cleared. It holds a 510(k) clearance under number K200185, granted to manufacturer VIOL Co., Ltd. on April 22, 2020. The clearance is for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. The important distinction for a clinic is that this is a clearance, not an approval, and that the cleared indication is electrocoagulation and hemostasis, not the specific aesthetic outcomes the device is often marketed for. Those aesthetic uses are clinical applications determined by the practitioner.
Is Sylfirm X FDA cleared or approved?
Cleared. The two words are not interchangeable in medical device regulation. Sylfirm X went through the FDA 510(k) premarket notification pathway, which establishes that a device is substantially equivalent to a legally marketed predicate device. That is different from premarket approval (PMA), the more demanding pathway used for higher-risk devices. Marketing that calls an aesthetic RF device "FDA approved" is using the wrong term, since these devices are cleared rather than approved. For a clinic, getting this right is not pedantry; it is the difference between accurate and inaccurate representation of a device's regulatory standing.
What the K200185 clearance covers
The clear indication, taken directly from the FDA document, is electrocoagulation and hemostasis in dermatologic and general surgical procedures. Sylfirm X is a Class II device under regulation 21 CFR 878.4400, product code GEI, in the electrosurgical cutting and coagulation category. Its clearance rested on substantial equivalence to two predicate devices, CELFIRM and SCARLET SRF, both also made by VIOL.
What this means in practice is that the clearance speaks to the device's mechanism, coagulating tissue through radiofrequency energy delivered by needle electrodes, rather than to a list of cosmetic claims. When a clinic sees Sylfirm X associated with pigment, laxity, or scarring, those are clinical uses of the cleared mechanism, applied at the practitioner's discretion, not separate FDA-cleared indications. Reading the clearance this way keeps a clinic's own patient communication accurate.
| FDA record field | Sylfirm X (K200185) |
|---|---|
| 510(k) number | K200185 |
| Decision date | April 22, 2020 |
| Manufacturer | VIOL Co., Ltd. |
| Regulation | 21 CFR 878.4400 (electrosurgical cutting and coagulation) |
| Device class | Class II, product code GEI |
| Cleared indication | Electrocoagulation and hemostasis in dermatologic and general surgical procedures |
| Predicates | CELFIRM (K172023), Scarlet SRF (K180872) |
How to verify a device's FDA status yourself
Any clinic can confirm a device's regulatory standing without relying on a seller's claim. The FDA publishes clearance records, and the Sylfirm X clearance document is available directly: FDA 510(k) clearance K200185. The steps are straightforward: note the 510(k) number, confirm the manufacturer name matches (VIOL Co., Ltd. for Sylfirm X), and read the indications-for-use statement rather than the marketing copy. The same method works for any RF microneedling device a clinic is evaluating.
FDA safety guidance on RF microneedling
On October 15, 2025, the FDA issued a safety communication, Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling, reporting serious complications associated with certain uses of these devices and stating that RF microneedling is a medical procedure rather than a cosmetic one. The reported concerns centered on devices used without appropriate clearance for the intended use, non-medical operators, and modified equipment. For a clinic, the takeaway is that verifying clearance and sourcing equipment with documented regulatory status is part of operating the procedure responsibly.
Frequently asked questions
Is Sylfirm X FDA approved or cleared?
Cleared, not approved. Sylfirm X holds a 510(k) clearance (K200185) based on substantial equivalence to predicate devices. Approval refers to the separate, more demanding PMA pathway. Aesthetic RF microneedling devices are generally cleared rather than approved, so "FDA cleared" is the accurate term.
What is the Sylfirm X 510(k) number?
The Sylfirm X 510(k) number is K200185, cleared on April 22, 2020 for manufacturer VIOL Co., Ltd. It is a Class II device under 21 CFR 878.4400, product code GEI, cleared for electrocoagulation and hemostasis in dermatologic and general surgical procedures.
Does FDA clearance guarantee treatment results?
No. Clearance addresses substantial equivalence and the safety of the device's mechanism, not the outcome of any particular treatment. The cleared indication is electrocoagulation and hemostasis. Specific aesthetic outcomes depend on the practitioner, the protocol, and the patient, and clearance makes no promise about them.
Sylfirm X is FDA cleared under 510(k) K200185 for electrocoagulation and hemostasis, a clearance rather than an approval, and one tied to the device mechanism rather than to cosmetic claims. Pinova carries professionally sourced Sylfirm X tips; compatibility is based on industry-standard usage and clinical experience; verify against your specific handpiece before ordering. Clinics sourcing for the platform can browse Sylfirm X tips and match consumables to the generation in use.
